{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJvW_-EKDA","type":"Investor","logokey":"$l5XLL7u3lPaEq6FIDtyqX4jY9ExGEQDE2YB5yvBXJ3j9wNR3iQzAyK","name":"SBI JI Innovation Fund","subtype":"VC and Private Equity","lastupdate":"2019-02-21T00:00:00.000Z","update_date":"2019-02-21T00:00:00.000Z","lastModified":"Jun 19, 2025","active":1,"confidence_score":45,"confidence_score_reason":"funding stage, product stage, sector, number of employees, business model, tag line, video or image, funding rounds, news, markets, external profiles, not claimed","urlname":"sbi-ji-innovation-fund","minimal_profile":null,"hide_reason":null,"status":"","fullstatus":"","hide_reason_data":null,"acquired":0,"description_edited":1,"tag_line_edited":0,"isisraeli":1,"country":"Israel","formernames":[],"min_date_investments":"2017-06-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":"515539617","founded_year":2017,"iia_supported":0,"currently_iia_supported":0,"alternativenames":["SBI-JI","SBI Japan-Israel Innovation Fund"],"managedassets":"Undisclosed","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"","website":"http://sbi-ji.co.il/","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"investmentstage":["C Round","B Round","A Round","F Round","D Round","E Round","Seed","G Round"],"about":"SBI JI Innovation Fund is a biopharma-focused venture capital fund. SBI JI was formed in early 2017 as a partnership between SBI Holdings, a Japanese-based financial services group; and Vertex, an Israeli venture capital investment firm investing in promising Israeli early-stage companies, with over $900 million under management. SBI JI cherry-picks Israeli or Israel-related venture-backed biopharma companies across different developmental stages. \r\n\r\nSBI JI is actively seeking companies that meet the following criteria: companies with state-of-the-art scientific foundations backed by a strong IP protection; companies that have already attracted investment from world-class investors; companies that have indications of inadequate or nonexistent therapies; companies managed by industry veterans, from executives to scientists; and companies with a rich therapeutic pipeline to follow the lead indication.","founded":"1/2017","education":null,"additional_activities":null,"events":null,"techcommunityinvolvement":null,"exits":[{"date":"Mar 2021","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"MQqfvbs2FzZdL8fshJOiOfDc8i2SHcB6N5GKcMMERauqnA9EIoc0KE","mnatype":null,"eventtype":"ReverseMergerEvent","valuation":"Undisclosed","wasacquired":null,"capitalraised":"Undisclosed","stockexchange":"NASDAQ","eventvisibility":null,"token_visibility":"","acquiredcompany_mna":"Chemomab Therapeutics","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMrEoLkKDA","acquiredcompany_reverse":"Anchiano Therapeutics","acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgO7j_OMIDA","acquiredcompany_mna_fullurl":"/company_page/chemomab","acquiredcompany_mna_logokey":"$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","acquiredcompany_mna_urlname":"chemomab","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":0,"acquiredcompany_reverse_fullurl":"/company_page/biocancell-therapeutics","acquiredcompany_reverse_logokey":"$3T7izMc6sH9yONnXrV84AfCeroSWV0kLhRIcdc5hAYPUt6TEMmo3y3","acquiredcompany_reverse_urlname":"biocancell-therapeutics","blurFinancialData":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"https://storage.googleapis.com/clean-finder-353810/$3T7izMc6sH9yONnXrV84AfCeroSWV0kLhRIcdc5hAYPUt6TEMmo3y3","style":"","hiddenCompanyTooltip":""},{"date":"May 2020","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCu4-elCAw","mnatype":null,"eventtype":"POEvent","valuation":"Undisclosed","wasacquired":null,"capitalraised":"$55M","stockexchange":"NASDAQ","eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"Ayala Pharmaceuticals","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/ayala-pharmaceuticals","acquiredcompany_mna_logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","acquiredcompany_mna_urlname":"ayala-pharmaceuticals","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""},{"date":"Nov 2019","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODanOzdCgw","mnatype":null,"eventtype":"ReverseMergerEvent","valuation":"Undisclosed","wasacquired":null,"capitalraised":"Undisclosed","stockexchange":"NYSE","eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"BiomX","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":"$gCUzHIIl5WdaUySSBVfr4ukCJPjuwKJMFXjiY09JCLUNERZRom14T0","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLfx744KDA","acquiredcompany_reverse":"Chardan Healthcare Acquisition Corp","acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCq_MHSCww","acquiredcompany_mna_fullurl":"/company_page/mbcure","acquiredcompany_mna_logokey":"$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","acquiredcompany_mna_urlname":"mbcure","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":1,"acquiredcompany_reverse_fullurl":"/company_page/chardan-healthcare-acquisition-corp","acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":"chardan-healthcare-acquisition-corp","blurFinancialData":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$gCUzHIIl5WdaUySSBVfr4ukCJPjuwKJMFXjiY09JCLUNERZRom14T0","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""},{"date":"Oct 2018","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODwq4PjCAw","mnatype":null,"eventtype":"POEvent","valuation":"$219.4M","wasacquired":null,"capitalraised":"$70M","stockexchange":"NASDAQ","eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"LogicBio Therapeutics","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwPiB7YoJDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/logicbio-therapeutics","acquiredcompany_mna_logokey":"$qeKx4KglBO8e1N6vNnpqx4SafE8hYaRbX2RJswjrq7gDJbLJLIMcn0","acquiredcompany_mna_urlname":"logicbio-therapeutics","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$qeKx4KglBO8e1N6vNnpqx4SafE8hYaRbX2RJswjrq7gDJbLJLIMcn0","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""}],"funds":[],"portfolio":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","name":"Ayala Pharmaceuticals","hidden":false,"raised":"$102M","founded":"2017","fullurl":"/company_page/ayala-pharmaceuticals","logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","urlname":"ayala-pharmaceuticals","employees":"11-50","description":"Targeted Therapies for People with Rare Cancers","fundingstage":"Acquired","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":102000000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLfx744KDA","name":"BiomX","hidden":false,"raised":"$143.5M","founded":"2015","fullurl":"/company_page/mbcure","logokey":"$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","urlname":"mbcure","employees":"51-200","description":"Microbiome Therapies for Chronic Diseases","fundingstage":"Public","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":143500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwL200okKDA","name":"Biond Biologics","hidden":false,"raised":"$37M","founded":"2016","fullurl":"/company_page/biond-biologics","logokey":"$8mrlUXSkMOmWT2wB3hmoAmRSFHenePpQ0CxSv2FCSxM77RvztYvmry","urlname":"biond-biologics","employees":"11-50","description":"Immunotherapies for Cancer and Auto-immune Diseases","fundingstage":"C","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":37000000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8mrlUXSkMOmWT2wB3hmoAmRSFHenePpQ0CxSv2FCSxM77RvztYvmry","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMrEoLkKDA","name":"Chemomab Therapeutics","hidden":false,"raised":"$90.5M","founded":"2011","fullurl":"/company_page/chemomab","logokey":"$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","urlname":"chemomab","employees":"11-50","description":"Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases","fundingstage":"Public","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":90500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoO7q_toLDA","name":"Cylus","hidden":false,"raised":"$54M","founded":"2017","fullurl":"/company_page/cylus","logokey":"$ZXbd4Hrr6kVKQVw5Xr7aohZ61ZI4eKSxxjxlm3yHyFanlkF2uhyux8","urlname":"cylus","employees":"51-200","description":"Railway Cybersecurity Solutions","fundingstage":"B","businessmodel":"B2B, B2G","minimalprofile":null,"eventvisibility":"Public","publicly_raised":54000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZXbd4Hrr6kVKQVw5Xr7aohZ61ZI4eKSxxjxlm3yHyFanlkF2uhyux8","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIfG0JsJDA","name":"ImmunoBrain Checkpoint","hidden":false,"raised":"undisclosed","founded":"2015","fullurl":"/company_page/immunobrain-checkpoint","logokey":"$88l3vLQzxyLWv0cS3tQQWA7GmcvYXj32v56L6QVYZtjqbvRcWvMkYd","urlname":"immunobrain-checkpoint","employees":"11-50","description":"Disease-modifying Immunotherapies for Neurodegenerative Disorders","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$88l3vLQzxyLWv0cS3tQQWA7GmcvYXj32v56L6QVYZtjqbvRcWvMkYd","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwPiB7YoJDA","name":"LogicBio Therapeutics","hidden":false,"raised":"$119M","founded":"2016","fullurl":"/company_page/logicbio-therapeutics","logokey":"$qeKx4KglBO8e1N6vNnpqx4SafE8hYaRbX2RJswjrq7gDJbLJLIMcn0","urlname":"logicbio-therapeutics","employees":"11-50","description":"Gene Therapy for Genetic and Infectious Diseases","fundingstage":"Mature","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":119000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$qeKx4KglBO8e1N6vNnpqx4SafE8hYaRbX2RJswjrq7gDJbLJLIMcn0","style":"","hiddenCompanyTooltip":""},{"id":"rsduVp6Bgcp6JbuGupuLBusNq378XzGqxj7pcrQ1kgSDs2khRNHxto","name":"ONE ZERO Digital Bank","hidden":false,"raised":"$182M","founded":"2019","fullurl":"/company_page/one-zero-digital-bank","logokey":"$kk0h86cR4iv77b5pXvj0iGKvZJ2pqwkCddXiggilWTv8xa7jlIl8Tr.jpeg","urlname":"one-zero-digital-bank","employees":"201-500","description":"Digital Private Banking","fundingstage":"Seed","businessmodel":"B2B, B2C","minimalprofile":null,"eventvisibility":"Public","publicly_raised":182000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$kk0h86cR4iv77b5pXvj0iGKvZJ2pqwkCddXiggilWTv8xa7jlIl8Tr.jpeg","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJmugaMKDA","name":"Orasis Pharmaceuticals","hidden":false,"raised":"$121M","founded":"2015","fullurl":"/company_page/orasis-pharmaceuticals","logokey":"$oHREd5hp1Kuvnd2U1bT2ATob8xs8myEfcvvZqcJXS1Pliwc2iMUE64","urlname":"orasis-pharmaceuticals","employees":"51-200","description":"Corrective Eye Drops for Presbyopia","fundingstage":"D","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":121000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$oHREd5hp1Kuvnd2U1bT2ATob8xs8myEfcvvZqcJXS1Pliwc2iMUE64","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgPmZyt4LDA","name":"Secret Double Octopus","hidden":false,"raised":"$41.5M","founded":"2015","fullurl":"/company_page/secret-double-octopus","logokey":"$tNguRc7JiDGkgAwvXZRh2HpK4TekMtqztmBXe7tWfpQrYpF0SKuDcs","urlname":"secret-double-octopus","employees":"11-50","description":"Passwordless Authentication Solution ","fundingstage":"C","businessmodel":"B2B, B2G","minimalprofile":null,"eventvisibility":"Public","publicly_raised":41500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$tNguRc7JiDGkgAwvXZRh2HpK4TekMtqztmBXe7tWfpQrYpF0SKuDcs","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Oct 2024","name":"Secret Double Octopus","amount":null,"hidden":false,"islead":1,"country":null,"eventid":"YVXvMZfftdNcb17D1mtIrl2Y2iP8Ehj7Ry5VkTzpgc0njjI2lhr7zF","fullurl":"/company_page/secret-double-octopus","logokey":"$tNguRc7JiDGkgAwvXZRh2HpK4TekMtqztmBXe7tWfpQrYpF0SKuDcs","tagline":"Passwordless Authentication Solution ","urlname":"/company_page/secret-double-octopus","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgPmZyt4LDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"C Round","investmentid":"0Npbaf7aHS3iATqfjCD7H8BdvvWOOLjezyHaAPSDYvby69i4ZxFY8U","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$tNguRc7JiDGkgAwvXZRh2HpK4TekMtqztmBXe7tWfpQrYpF0SKuDcs","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Oct 2024","name":"Orasis Pharmaceuticals","amount":78000000,"hidden":false,"islead":0,"country":null,"eventid":"N8gGCPpaBjTBPzXDG0UdxluiYknSwsSf3Eh2VBJB3NecJGgYk9yvyT","fullurl":"/company_page/orasis-pharmaceuticals","logokey":"$oHREd5hp1Kuvnd2U1bT2ATob8xs8myEfcvvZqcJXS1Pliwc2iMUE64","tagline":"Corrective Eye Drops for Presbyopia","urlname":"/company_page/orasis-pharmaceuticals","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJmugaMKDA","isfollowon":1,"companytype":"Startup","eventamount":"$78M","fundingtype":"D Round","investmentid":"tEHgfnXCfWqts1XZlkJLZN800xIO5ugy4aujBNFg322OzxXw5X4Z5P","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$oHREd5hp1Kuvnd2U1bT2ATob8xs8myEfcvvZqcJXS1Pliwc2iMUE64","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Feb 2023","name":"ONE ZERO Digital Bank","amount":62000000,"hidden":false,"islead":0,"country":null,"eventid":"k0ahykvaUpJY19wjVJI2V0g1a89JJvINnyLKOEWwMrsbWMK6Yn667d","fullurl":"/company_page/one-zero-digital-bank","logokey":"$kk0h86cR4iv77b5pXvj0iGKvZJ2pqwkCddXiggilWTv8xa7jlIl8Tr.jpeg","tagline":"Digital Private Banking","urlname":"/company_page/one-zero-digital-bank","companyid":"rsduVp6Bgcp6JbuGupuLBusNq378XzGqxj7pcrQ1kgSDs2khRNHxto","isfollowon":0,"companytype":"Startup","eventamount":"$62M","fundingtype":"Undisclosed Round","investmentid":"R9fDrSGxvVxouqs0UpG6MxXZhCyegHuq4hAyuc0BKeAkUTCYwqyqbI","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$kk0h86cR4iv77b5pXvj0iGKvZJ2pqwkCddXiggilWTv8xa7jlIl8Tr.jpeg","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Sep 2020","name":"Orasis Pharmaceuticals","amount":30000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODZ64WTCgw","fullurl":"/company_page/orasis-pharmaceuticals","logokey":"$oHREd5hp1Kuvnd2U1bT2ATob8xs8myEfcvvZqcJXS1Pliwc2iMUE64","tagline":"Corrective Eye Drops for Presbyopia","urlname":"/company_page/orasis-pharmaceuticals","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJmugaMKDA","isfollowon":1,"companytype":"Startup","eventamount":"$30M","fundingtype":"C Round","investmentid":"c9c5a57b-a5db-4b0e-8eec-d1bdfedd79bd","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$oHREd5hp1Kuvnd2U1bT2ATob8xs8myEfcvvZqcJXS1Pliwc2iMUE64","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2019","name":"Chemomab Therapeutics","amount":20000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC7mtuBCQw","fullurl":"/company_page/chemomab","logokey":"$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","tagline":"Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases","urlname":"/company_page/chemomab","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMrEoLkKDA","isfollowon":1,"companytype":"Startup","eventamount":"$20M","fundingtype":"C Round","investmentid":"ba5cc8bc-0077-4e3c-b715-02ae0527721c","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jun 2019","name":"Cylus","amount":12000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODU3seWCgw","fullurl":"/company_page/cylus","logokey":"$ZXbd4Hrr6kVKQVw5Xr7aohZ61ZI4eKSxxjxlm3yHyFanlkF2uhyux8","tagline":"Railway Cybersecurity Solutions","urlname":"/company_page/cylus","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoO7q_toLDA","isfollowon":0,"companytype":"Startup","eventamount":"$12M","fundingtype":"A Round","investmentid":"d240a643-55e3-4869-ae69-7ac422bc618f","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZXbd4Hrr6kVKQVw5Xr7aohZ61ZI4eKSxxjxlm3yHyFanlkF2uhyux8","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2019","name":"Ayala Pharmaceuticals","amount":30000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCUz_rHCgw","fullurl":"/company_page/ayala-pharmaceuticals","logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","tagline":"Targeted Therapies for People with Rare Cancers","urlname":"/company_page/ayala-pharmaceuticals","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","isfollowon":0,"companytype":"Startup","eventamount":"$30M","fundingtype":"B Round","investmentid":"pVYlkJ8YjcIw40OPzAkQ6O5TXeRJw3V2yDMgCpLvqeiXv7Lio90LAi","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Feb 2019","name":"BiomX","amount":32000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODY5cbcCAw","fullurl":"/company_page/mbcure","logokey":"$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","tagline":"Microbiome Therapies for Chronic Diseases","urlname":"/company_page/mbcure","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLfx744KDA","isfollowon":0,"companytype":"Startup","eventamount":"$32M","fundingtype":"B Round","investmentid":"c212bc3e-d708-4e88-9301-ebac9f6ee346","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2019","name":"Biond Biologics","amount":17000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtfrMCAw","fullurl":"/company_page/biond-biologics","logokey":"$8mrlUXSkMOmWT2wB3hmoAmRSFHenePpQ0CxSv2FCSxM77RvztYvmry","tagline":"Immunotherapies for Cancer and Auto-immune Diseases","urlname":"/company_page/biond-biologics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwL200okKDA","isfollowon":0,"companytype":"Startup","eventamount":"$17M","fundingtype":"B Round","investmentid":"5d72a8c2-b2a2-477d-a309-5187ef926bdd","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":null,"leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8mrlUXSkMOmWT2wB3hmoAmRSFHenePpQ0CxSv2FCSxM77RvztYvmry","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jun 2018","name":"Orasis Pharmaceuticals","amount":13000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4juaICww","fullurl":"/company_page/orasis-pharmaceuticals","logokey":"$oHREd5hp1Kuvnd2U1bT2ATob8xs8myEfcvvZqcJXS1Pliwc2iMUE64","tagline":"Corrective Eye Drops for Presbyopia","urlname":"/company_page/orasis-pharmaceuticals","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJmugaMKDA","isfollowon":0,"companytype":"Startup","eventamount":"$13M","fundingtype":"B Round","investmentid":"f2e50a99-1f77-4bbd-af2a-0aa5e278d148","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$oHREd5hp1Kuvnd2U1bT2ATob8xs8myEfcvvZqcJXS1Pliwc2iMUE64","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2017","name":"Chemomab Therapeutics","amount":10000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkw_XcCAw","fullurl":"/company_page/chemomab","logokey":"$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","tagline":"Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases","urlname":"/company_page/chemomab","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMrEoLkKDA","isfollowon":0,"companytype":"Startup","eventamount":"$10M","fundingtype":"B Round","investmentid":"c1ea339d-ec6f-423f-8942-714311eb09b6","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Oct 2017","name":"ImmunoBrain Checkpoint","amount":0,"hidden":false,"islead":null,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtez1CQw","fullurl":"/company_page/immunobrain-checkpoint","logokey":"$88l3vLQzxyLWv0cS3tQQWA7GmcvYXj32v56L6QVYZtjqbvRcWvMkYd","tagline":"Disease-modifying Immunotherapies for Neurodegenerative Disorders","urlname":"/company_page/immunobrain-checkpoint","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIfG0JsJDA","isfollowon":null,"companytype":"Startup","eventamount":"$0","fundingtype":"Undisclosed Round","investmentid":"078dae41-60a9-4c97-bb08-ea5c16059622","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$88l3vLQzxyLWv0cS3tQQWA7GmcvYXj32v56L6QVYZtjqbvRcWvMkYd","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jun 2017","name":"LogicBio Therapeutics","amount":45000000,"hidden":false,"islead":null,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEv_ezCww","fullurl":"/company_page/logicbio-therapeutics","logokey":"$qeKx4KglBO8e1N6vNnpqx4SafE8hYaRbX2RJswjrq7gDJbLJLIMcn0","tagline":"Gene Therapy for Genetic and Infectious Diseases","urlname":"/company_page/logicbio-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwPiB7YoJDA","isfollowon":null,"companytype":"Startup","eventamount":"$45M","fundingtype":"B Round","investmentid":"0f71b4c3-9d4a-4563-8af3-41c214b2911e","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$qeKx4KglBO8e1N6vNnpqx4SafE8hYaRbX2RJswjrq7gDJbLJLIMcn0","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""}],"team":[{"name":"Masa Tanaka","email":"masa@sbi-ji.co.il","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoIfolc0IDA","bounced":true,"claimed":0,"founder":1,"urlname":"masa-tanaka","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgh-japQkM","position":"President","last_name":"Tanaka","claimtoken":"b1a90c8dac0cf899748c3fdd7719fae6da0d5569621b19add2f9f643818b23f4","first_name":"Masa","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/masa-tanaka-29911585/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"MT","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ryo Nakashima","email":"ryo@sbi-ji.co.il","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4N3jtrELDA","bounced":true,"claimed":0,"founder":0,"urlname":"ryo-nakashima","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg_euCiAoM","position":"Managing Director","last_name":"Nakashima","claimtoken":"b20f12b437b490fa3bd296ee841f58959fbe4264d983a833131f1c5236c51b3d","first_name":"Ryo","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ryo-nakashima-0912/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-11-26 11:24:55.000000","initials":"RN","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"David HELLER","email":"david@vertexventures.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgP2lgIkKDA","bounced":false,"claimed":0,"founder":1,"urlname":"david-heller-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgu9-ykAoM","position":"General Partner","last_name":"HELLER","claimtoken":"d948bb46ed0629ce24b773f2f3a74f995c2cdf8f893b99b93c728aba03280013","first_name":"David","picturekey":"$kdFETOwDtBt4X30FAUHrP6SNoQPZm4ZhO6XAS82RjDxLy3LvUMhRSK","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/david-heller-28b28288/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$kdFETOwDtBt4X30FAUHrP6SNoQPZm4ZhO6XAS82RjDxLy3LvUMhRSK","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ran Gartenberg","email":"ran@sbi-ji.co.il","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoIeJ0ZUKDA","bounced":true,"claimed":0,"founder":1,"urlname":"ran-gartenberg-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgh4m8mQsM","position":"General Partner & CFO","last_name":"Gartenberg","claimtoken":"f32bbe21b21d6ed663917bb20af82c0945f59ce1053a61d6f963f938a6e0d018","first_name":"Ran","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ran-gartenberg-0852583/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"RG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Suni Kim","email":"sunikim@mintogp.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPO29aQIDA","bounced":false,"claimed":0,"founder":0,"urlname":"suni-kim-1","visible":0,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgg8_X0wkM","position":"Financial Professional","last_name":"Kim","claimtoken":"500fc99064de6cc6427c2ac227c6551bc0ba6099c9cc2d7c65c56d3dab4c0b4e","first_name":"Suni","picturekey":"$7bImCoQXwehtaPlnOR0tLbGIke2YLQApzx8exqUaY8apUMt7gRkxoI","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/sunikim","unsubscribed":false,"is_activeuser":1,"additionalemail":"sunikim@mintogp.com","claimedemaildate":"2020-11-26 08:47:15.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$7bImCoQXwehtaPlnOR0tLbGIke2YLQApzx8exqUaY8apUMt7gRkxoI","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>private</text>\n</div>'"}],"tags":["chronic-disease","oncology","biopharmaceutical","cancer","pharmaceuticals","fintech","cyber-security","biotechnology","insurtech","genetic-disorders"],"targetmarkets":[],"phone":"+97237485103","address":{"israeli":[{"id":"ab151fbc-d47e-45e1-85b4-9f1bb02c13fc","city":"Tel Aviv-Yafo","type":null,"address":"HaArba'a Street 28, Tel Aviv-Yafo, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"95638f86-fdaa-48f1-8968-4704dea3a123","city":null,"address":"Japan","country":"Japan","placeid":null}]},"headquarter_address":"","news":[],"newsNumber":0,"mediagallery":[],"biverification":"Jenny Sotnik-Talisman","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-04-01T00:00:00.000Z","crunchbaseid":"sbi-japan-israel-innovation-fund","lastupdator":"Yotam Maman","lastupdator_email":"yotamm1988@gmail.com","creator":"Yotam Maman","creator_email":"yotamm1988@gmail.com","createdate":"2019-02-21T00:00:00.000Z","recentupdates":[{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:55.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:55.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:53.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Automatic","datetime":"2025-04-06 12:53:55.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:55.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:53.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-19 09:13:32.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-19 09:13:32.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-19 09:13:32.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-19 09:13:31.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-19 09:13:31.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-19 09:13:31.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:54.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:53.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:55:09.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:55:09.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:02:42.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:50:15.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:50:17.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:50:17.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:55:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:55:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2019-02-24 14:20:00.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2019-02-24 14:20:00.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:02:46.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:00:57.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:01:01.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:57:38.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:55:42.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:55:42.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:59:02.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:01:42.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:47:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:47:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:47:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:47:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:47:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:47:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:47:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:47:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:03:28.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:06:01.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:06:01.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:57:20.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:57:20.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:03:28.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:45:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:45:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:45:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:45:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:45:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:45:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:45:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:58:57.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:03:27.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:50:36.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:50:36.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:58:01.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:03:29.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:05:14.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:56:29.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:59:39.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 07:50:16.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-02-21 08:03:29.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 09:32:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 09:32:27.000000","last_name":"Maman","first_name":"Yotam"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-26 11:24:52.000000","last_name":"Kim","first_name":"Suni"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-26 11:26:57.000000","last_name":"Kim","first_name":"Suni"},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-03-26 15:26:55.000000","last_name":"Nielsen","first_name":"L."},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-04-22 15:07:36.000000","last_name":"Nielsen","first_name":"L."},{"email":"saraiahrak99@gmail.com","source":"Manual","datetime":"2020-11-26 08:46:33.000000","last_name":"Ahrak","first_name":"Sarai"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-12-24 07:25:48.000000","last_name":"Maman","first_name":"Yotam"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-10-14 07:18:43.000000","last_name":"Kim","first_name":"Suni"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-26 11:26:55.000000","last_name":"Kim","first_name":"Suni"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-26 11:27:40.000000","last_name":"Kim","first_name":"Suni"},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-03-26 15:34:33.000000","last_name":"Nielsen","first_name":"L."},{"email":"saraiahrak99@gmail.com","source":"Manual","datetime":"2020-10-26 07:11:54.000000","last_name":"Ahrak","first_name":"Sarai"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-12-24 07:26:09.000000","last_name":"Maman","first_name":"Yotam"},{"email":"saraiahrak99@gmail.com","source":"Manual","datetime":"2020-10-14 07:13:34.000000","last_name":"Ahrak","first_name":"Sarai"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-10-14 07:15:28.000000","last_name":"Kim","first_name":"Suni"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-25 13:12:44.000000","last_name":"Kim","first_name":"Suni"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-08-22 06:38:35.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 09:31:50.000000","last_name":"Maman","first_name":"Yotam"},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-03-26 15:25:42.000000","last_name":"Nielsen","first_name":"L."},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-03-26 15:27:47.000000","last_name":"Nielsen","first_name":"L."},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-04-01 06:36:17.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-12-24 07:25:26.000000","last_name":"Maman","first_name":"Yotam"},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-03-26 15:22:49.000000","last_name":"Nielsen","first_name":"L."},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-03-26 15:22:49.000000","last_name":"Nielsen","first_name":"L."},{"email":"saraiahrak99@gmail.com","source":"Manual","datetime":"2020-10-26 07:11:40.000000","last_name":"Ahrak","first_name":"Sarai"},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-04-22 15:07:36.000000","last_name":"Nielsen","first_name":"L."},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-26 11:26:59.000000","last_name":"Kim","first_name":"Suni"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-26 11:26:57.000000","last_name":"Kim","first_name":"Suni"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-26 11:25:08.000000","last_name":"Kim","first_name":"Suni"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-26 11:27:01.000000","last_name":"Kim","first_name":"Suni"},{"email":"sunikim@mintogp.com","source":"Manual","datetime":"2020-11-26 11:27:01.000000","last_name":"Kim","first_name":"Suni"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-16 09:31:56.000000","last_name":"Maman","first_name":"Yotam"},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2019-03-26 15:28:34.000000","last_name":"Nielsen","first_name":"L."},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:53.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-19 09:13:33.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"jenny.sotnik@sncentral.org","source":"Automatic","datetime":"2025-04-06 12:53:55.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:53.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:53.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:54.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-06 12:53:53.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-19 09:13:30.000000","last_name":"Eblagon","first_name":"Matan"}],"rounds_per_sector":[{"count":10,"sector":"Health Tech & Life Sciences"},{"count":2,"sector":"Cyber Security"},{"count":1,"sector":"Fintech & Insurtech"}],"rounds_per_stage":[{"count":1,"isfollowon":0,"fundingStage":"A Round"},{"count":6,"isfollowon":0,"fundingStage":"B Round"},{"count":1,"isfollowon":0,"fundingStage":"C Round"},{"count":2,"isfollowon":1,"fundingStage":"C Round"},{"count":1,"isfollowon":1,"fundingStage":"D Round"},{"count":2,"isfollowon":0,"fundingStage":"Undisclosed"}],"investment_rounds_over_time":[{"year":2017,"month":6,"record_count":1},{"year":2017,"month":10,"record_count":1},{"year":2017,"month":12,"record_count":1},{"year":2018,"month":6,"record_count":1},{"year":2019,"month":1,"record_count":1},{"year":2019,"month":2,"record_count":1},{"year":2019,"month":5,"record_count":1},{"year":2019,"month":6,"record_count":1},{"year":2019,"month":12,"record_count":1},{"year":2020,"month":9,"record_count":1},{"year":2023,"month":2,"record_count":1},{"year":2024,"month":10,"record_count":2}],"portfolio_companies_per_sector":[{"count":7,"sector":"Health Tech & Life Sciences"},{"count":2,"sector":"Cyber Security"},{"count":1,"sector":"Fintech & Insurtech"}],"new_portfolio_companies_over_time":[{"year":2017,"month":6,"record_count":1},{"year":2017,"month":10,"record_count":1},{"year":2017,"month":12,"record_count":1},{"year":2018,"month":6,"record_count":1},{"year":2019,"month":1,"record_count":1},{"year":2019,"month":2,"record_count":1},{"year":2019,"month":5,"record_count":1},{"year":2019,"month":6,"record_count":1},{"year":2023,"month":2,"record_count":1},{"year":2024,"month":10,"record_count":1}],"exits_over_time":[{"year":2018,"count":1,"eventType":"POEvent"},{"year":2021,"count":2,"eventType":"ReverseMergerEvent"},{"year":2019,"count":1,"eventType":"ReverseMergerEvent"},{"year":2020,"count":1,"eventType":"POEvent"}],"exits_by_sector":[{"count":4,"sector":"Health Tech & Life Sciences"}],"affiliatedOrganizations":null,"timeline":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"VC and Private Equity","parsedName":"SBI JI Innovation Fund","logourl":"https://storage.googleapis.com/clean-finder-353810/$l5XLL7u3lPaEq6FIDtyqX4jY9ExGEQDE2YB5yvBXJ3j9wNR3iQzAyK","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$l5XLL7u3lPaEq6FIDtyqX4jY9ExGEQDE2YB5yvBXJ3j9wNR3iQzAyK","teamMembersNumber":5,"section":null,"sectionParams":"","queryParams":"","seoabout":"SBI JI Innovation Fund is a biopharma-focused venture capital fund. SBI JI was formed in early 2017 as a partnership between SBI Holdings, a Japanese-based...","seoTitle":"Israeli VC and Private Equity","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"A Round\",\"newInvestments\":1,\"followOnInvestments\":0},{\"fundingStage\":\"B Round\",\"newInvestments\":6,\"followOnInvestments\":0},{\"fundingStage\":\"C Round\",\"newInvestments\":1,\"followOnInvestments\":2},{\"fundingStage\":\"D Round\",\"newInvestments\":0,\"followOnInvestments\":1},{\"fundingStage\":\"Undisclosed\",\"newInvestments\":2,\"followOnInvestments\":0}],\"investmentRoundsBySector\":[{\"count\":10,\"sector\":\"Health Tech & Life Sciences\"},{\"count\":2,\"sector\":\"Cyber Security\"},{\"count\":1,\"sector\":\"Fintech & Insurtech\"}],\"investmentRoundsOverTime\":[{\"label\":\"2017\",\"count\":3},{\"label\":\"2018\",\"count\":1},{\"label\":\"2019\",\"count\":5},{\"label\":\"2020\",\"count\":1},{\"label\":\"2021\",\"count\":0},{\"label\":\"2022\",\"count\":0},{\"label\":\"2023\",\"count\":1},{\"label\":\"2024\",\"count\":2},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":7,\"sector\":\"Health Tech & Life Sciences\"},{\"count\":2,\"sector\":\"Cyber Security\"},{\"count\":1,\"sector\":\"Fintech & Insurtech\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2017\",\"count\":3},{\"label\":\"2018\",\"count\":1},{\"label\":\"2019\",\"count\":4},{\"label\":\"2020\",\"count\":0},{\"label\":\"2021\",\"count\":0},{\"label\":\"2022\",\"count\":0},{\"label\":\"2023\",\"count\":1},{\"label\":\"2024\",\"count\":1},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[{\"year\":2018,\"count\":1,\"eventType\":\"POEvent\"},{\"year\":2021,\"count\":2,\"eventType\":\"ReverseMergerEvent\"},{\"year\":2019,\"count\":1,\"eventType\":\"ReverseMergerEvent\"},{\"year\":2020,\"count\":1,\"eventType\":\"POEvent\"},{\"year\":2017,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2017,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2022,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2023,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2023,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2024,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2024,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2025,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2025,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2026,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2026,\"count\":0,\"eventType\":\"publicExits\"}],\"exitsBySector\":[{\"count\":4,\"sector\":\"Health Tech & Life Sciences\"}]}","statusinfo":"","iiasupport":"","managedAssetsNumber":null,"investmentrange":"$10M - $78M","communityinvolvement":[],"foreignInvestments":"","nationality":"Israeli","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{}}